Health

The Trump administration has released rules for new Medicaid work requirements, with states moving quickly to implement them before next year.

Updated American Cancer Society guidance keeps colonoscopy and stool tests as primary screening paths for average-risk adults, while adding new stool-based molecular testing and a blood-based option.

Researchers at Karolinska Institutet report that microglia can build a fibronectin-rich scaffold that appears to help diffuse midline glioma cells invade nearby brain tissue.

A new global analysis finds mental health disorders are now the leading cause of disability worldwide, with anxiety and depression rising sharply since the pandemic.

A first-in-human phase 1 study of IMA401 found manageable side effects and early antitumor activity in advanced solid tumors.

A report from STAT says ultra-low doses may help costly cancer treatments reach more patients in poorer countries, putting affordability at the center of oncology access.

A report highlighted ultra-low-dose immunotherapy as a possible way to widen access to expensive cancer treatment in poorer countries.

An early clinical trial suggests a single infusion of VERVE-102 can sharply lower LDL cholesterol, pointing to a possible alternative to lifelong medication.

Health warnings in Australia are highlighting the danger of Murray Valley encephalitis after two deaths near Alice Springs, with prevention focused on avoiding mosquito bites because no vaccine is available.

At ASCO, BioNTech and Pfizer promoted new bispecific cancer data while senior FDA oncology official Rick Pazdur argued agency disruption could become a chance to rebuild.

Revolution Medicines has started shipping an experimental pancreatic cancer drug, and its CEO says an FDA submission is coming soon.

A study in The Lancet Public Health found Flint’s Rx Kids program was associated with lower preterm birth, lower low-birthweight rates, and fewer NICU admissions.

Researchers at Washington University say an AI-assisted blood test distinguished four major neurodegenerative diseases and healthy aging with more than 90% accuracy.

A Nature Medicine research briefing describes gut microbiome changes that track from healthy people to genetically at-risk groups and symptomatic Parkinson’s patients, suggesting earlier screening may be possible.

A court in Kenya has suspended a U.S. plan to create a quarantine facility for Americans exposed to Ebola as the outbreak continues in northeastern Congo.

Researchers using patient-derived tissue and stem-cell models reported that RNA therapy reduced harmful protein aggregation in a form of inherited cardiomyopathy linked to the PLN R14del variant.

Phase III trial results reported in the New England Journal of Medicine showed roughly one in five chronic hepatitis B patients achieved a functional cure after 24 weeks of bepirovirsen.

Researchers at Gladstone Institutes developed a way to trace how waste leaves the brain, revealing specific clearance routes and how Alzheimer’s disrupts them.

Researchers at King’s College London say antibiotics can be redesigned to resist bacterial efflux pumps, potentially reviving older drug classes and improving new ones.

As an Ebola outbreak grows in Central Africa, the U.S. response is being framed around keeping the virus out, but the available report warns that approach may create its own risks.